The RNA Editing Market Size is valued at USD 15.2 billion in 2023 and is predicted to reach USD 23.1 billion by the year 2031 at a 5.60% CAGR during the forecast period for 2024-2031.
RNA editing performs a crucial role in the nervous system, immune response, and cellular adaptation. It is a key focus in biomedical research for its potential in treating genetic disorders, cancer, and other diseases where RNA modification could offer therapeutic benefits. RNA Editing is a molecular procedure in which some cells can make changes to specific nucleotides sequenced within an RNA molecule. It also includes insertion, Deletion, and base substitution of nucleotides within the RNA molecule. Hence, the adoption of RNA Editing is expected to increase in the near future as concerns grow over the healthcare sector.
The rising number of chronic diseases and disorders are the factors expected to drive the growth of the global RNA Editing market. Advancements in CRISPR-Based RNA editing, the rapid expansion of RNA editing, and increasing investment are some of the other factors estimated to augment the target market growth. Additionally, The increasing expansion of genome editing applications globally is expected to boost market expansion in the coming years.
Nevertheless, the target market's growth may be restricted by the COVID-19 outbreak, recalls of RNA therapeutic products, and off-target effects of RNA editing during the forecast period. Additionally, the global RNA Editing market is anticipated to generate lucrative revenue growth opportunities for players over the forecast period as a result of the expansion of R&D activities, government initiatives to incorporate sustainable components into production, and investments by prominent players.
The RNA Editing market is categorized based on the type of RNA, application, and technique. The Type segment consists of messenger RNA Modification, Transfer RNA modification, Ribosomal RNA Modification. The application segment includes cancer, genetic disorders, and temporary maladies. By technique, the market is segmented into insertion/Deletion and Deamination.
The messenger, RNA Modification category, is expected to hold a major share of the global RNA Editing market. This is attributed to playing an important role in gene expression. In gene expression, the genetic information is transferred from the DNA to the ribosomes. Additionally, RNA modifications also control mRNA stability, localization, splicing, and translation efficiency.
The deamination segment is projected to grow at a rapid rate in the global RNA Editing market owing to growing concerns about the conversion of specific nucleotide bases within RNA molecules. Hence, with the growing demand for deamination, there is an increase in demand for RNA Editing in the healthcare sector.
The North American RNA Editing market is expected to record the prominent market share in terms of revenue in the upcoming future. This can be attributed to the strong focus on healthcare in the region, with the increasing adoption of RNA Editing due to the rising cases of genome editing. In addition, the healthcare industry in the region is focusing on the production of RNA Editing technology. Growing research & development activities and rapid innovations in the region are the significant factors proliferating the growth of the desired market in the region. In addition, Asia Pacific region is likely to grow very fast in the global RNA Editing market due to growing collaborations among local academic institutions, biotech businesses, government initiatives, and increasing funding from foreign partners.
|
Report Attribute |
Specifications |
|
Market Size Value In 2023 |
USD 15.2 Bn |
|
Revenue Forecast In 2031 |
USD 23.1 Bn |
|
Growth Rate CAGR |
CAGR of 5.60% from 2024 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Bn and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Type Of RNA, Application, And Technique |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South East Asia; South Korea |
|
Competitive Landscape |
ProQR Therapeutics NV, Sirna Therapeutics, Inc., Shape Therapeutics, Inc., Korro Bio, In., Beam Therapeutics, Inc., QIAGEN N.V., UniquQuire NV, LAVA Therapeutics N.V., argenx SE, Arrowhead Pharmaceuticals, Inc. |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global RNA Editing Market Snapshot
Chapter 4. Global RNA Editing Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2024-2031
4.8. Global RNA Editing Market Penetration & Growth Prospect Mapping (US$ Mn), 2023-2031
4.9. Competitive Landscape & Market Share Analysis, By Key Player (2023)
4.10. Use/impact of AI on RNA Editing Industry Trends
Chapter 5. RNA Editing Market Segmentation 1: By Type of RNA, Estimates & Trend Analysis
5.1. Market Share by Type of RNA, 2023 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following Type of RNA:
5.2.1. Messenger RNA Modification
5.2.2. Transfer RNA Modification
5.2.3. Ribosomal RNA Modification
Chapter 6. RNA Editing Market Segmentation 2: By Application, Estimates & Trend Analysis
6.1. Market Share by Application, 2023 & 2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following Applications:
6.2.1. Cancer
6.2.2. Genetic Disorders
6.2.3. Temporary Maladie
Chapter 7. RNA Editing Market Segmentation 3: By Technique, Estimates & Trend Analysis
7.1. Market Share by Technique, 2023 & 2031
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following Techniques:
7.2.1. Insertion/ Deletion
7.2.2. Deamination
Chapter 8. RNA Editing Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. Global RNA Editing Market, Regional Snapshot 2023 & 2031
8.2. North America
8.2.1. North America RNA Editing Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031
8.2.1.1. US
8.2.1.2. Canada
8.2.2. North America RNA Editing Market Revenue (US$ Million) Estimates and Forecasts by Type of RNA, 2024-2031
8.2.3. North America RNA Editing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.2.4. North America RNA Editing Market Revenue (US$ Million) Estimates and Forecasts by Technique, 2024-2031
8.3. Europe
8.3.1. Europe RNA Editing Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031
8.3.1.1. Germany
8.3.1.2. U.K.
8.3.1.3. France
8.3.1.4. Italy
8.3.1.5. Spain
8.3.1.6. Rest of Europe
8.3.2. Europe RNA Editing Market Revenue (US$ Million) Estimates and Forecasts by Type of RNA, 2024-2031
8.3.3. Europe RNA Editing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.3.4. Europe RNA Editing Market Revenue (US$ Million) Estimates and Forecasts by Technique, 2024-2031
8.4. Asia Pacific
8.4.1. Asia Pacific RNA Editing Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031
8.4.1.1. India
8.4.1.2. China
8.4.1.3. Japan
8.4.1.4. Australia
8.4.1.5. South Korea
8.4.1.6. Hong Kong
8.4.1.7. Southeast Asia
8.4.1.8. Rest of Asia Pacific
8.4.2. Asia Pacific RNA Editing Market Revenue (US$ Million) Estimates and Forecasts by Type of RNA, 2024-2031
8.4.3. Asia Pacific RNA Editing Market Revenue (US$ Million) Estimates and Forecasts By Application, 2024-2031
8.4.4. Asia Pacific RNA Editing Market Revenue (US$ Million) Estimates and Forecasts by Technique, 2024-2031
8.5. Latin America
8.5.1. Latin America RNA Editing Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031
8.5.1.1. Brazil
8.5.1.2. Mexico
8.5.1.3. Rest of Latin America
8.5.2. Latin America RNA Editing Market Revenue (US$ Million) Estimates and Forecasts by Type of RNA, 2024-2031
8.5.3. Latin America RNA Editing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.5.4. Latin America RNA Editing Market Revenue (US$ Million) Estimates and Forecasts by Technique, 2024-2031
8.6. Middle East & Africa
8.6.1. Middle East & Africa RNA Editing Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.6.1.1. GCC Countries
8.6.1.2. Israel
8.6.1.3. South Africa
8.6.1.4. Rest of Middle East and Africa
8.6.2. Middle East & Africa RNA Editing Market Revenue (US$ Million) Estimates and Forecasts by Type of RNA, 2024-2031
8.6.3. Middle East & Africa RNA Editing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.6.4. Middle East & Africa RNA Editing Market Revenue (US$ Million) Estimates and Forecasts by Technique, 2024-2031
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. ProQR Therapeutics NV
9.2.1.1. Business Overview
9.2.1.2. Key Product/Service Offerings
9.2.1.3. Financial Performance
9.2.1.4. Geographical Presence
9.2.1.5. Recent Developments with Business Strategy
9.2.2. Sirna Therapeutics, Inc.
9.2.3. Shape Therapeutics, Inc.
9.2.4. Korro Bio, Inc.
9.2.5. Beam Therapeutics, Inc.
9.2.6. QIAGEN N.V.
9.2.7. UniQure NV (UniQure)
9.2.8. LAVA Therapeutics N.V.
9.2.9. argenx SE
9.2.10. Arrowhead Pharmaceuticals, Inc.
9.2.11. Other Prominent Players
RNA Editing Market By Type-
RNA Editing Market By Application-
RNA Editing Market By Technique-
RNA Editing Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
